Apollo Funds Close €3 Billion Capital Solution for Bayer With KKR as Minority Partner

Corporate Action
โดย GlobeNewswire·DEUS·Read original
Summary · why it matters

Apollo-managed funds and affiliates have closed a €3 billion capital solution for Bayer, first announced on July 10, with KKR joining as a significant minority participant. Under the transaction, Apollo and KKR invested equity capital into a newly established entity holding Bayer's long-acting reversible contraceptives business, while Bayer retains a majority stake and continues to exercise full operational control, with no changes to the LARC strategy. Apollo Partner Jamshid Ehsani said the firm originated and led the multi-billion-euro capital solution, adding that Apollo has committed to deploying more than $100 billion in Germany over the coming decade. Centerview Partners served as financial advisor to the Apollo Funds, with Latham & Watkins LLP, Paul, Weiss, Rifkind, Wharton & Garrison LLP, and NautaDutilh N.V. acting as legal counsel.

Impact on stocks 3

Aging Population▲ · 2 stocks
KKR & Co. Inc.
KKR
▲ PositiveCapitalrelevance

KKR joined as a significant minority participant in the €3B equity investment into Bayer's LARC entity.

Health Care▲ · 1 stocks
Bayer AG NA
BAYN
▲ PositiveCapitalrelevance

Bayer closed a €3B capital solution with Apollo and KKR while retaining majority stake and full operational control of its LARC business.

Off-coverage companies 2

Latham & Watkins LLPPrivate± Mixed
relevance

NautaDutilh N.V.Private± Mixed
relevance

© 2026 MarketDXNews